Showing 871-880 of 1440 results for "".
- Medical Laser Market to Reach $17.3 Billion Over Next 6 Yearshttps://modernaesthetics.com/news/medical-laser-market-to-reach-173-billion-over-next-6-years/2473589/New research projects the medical laser market will be worth $17.3 billion by 2031. The report titled "Medical Laser Market by Type (Device Type (Solid-state Lasers, Gas Lasers, Dye Lasers, Diode Lasers), Fiber Type (Disposable Laser Fibers, Reusable Laser Fibers)), Application (De
- Highlights From IMCAS World Congress 2024: 25 years at the Forefront of Medical Aesthetics and Countinghttps://modernaesthetics.com/news/highlights-from-imcas-world-congress-2024-25-years-at-the-forefront-of-medical-aesthetics-and-counting-1/2473561/As a veteran of the International Master Course on Aging Science (IMCAS) for over two decades, IMCAS 2024 was the largest congress to date with over 18,000 attendees in the Palais des Congres. Located in central Paris, we had to navigate a construction zone as workmen were busy getting the city r
- Lumenis Debuts Stellar M22™ with XPL™ at ASDS 2025, Showcases Single-Session Clearance Datahttps://modernaesthetics.com/news/lumenis-debuts-stellar-m22-with-xpl-at-asds-2025-showcases-single-session-clearance-data/2484554/Lumenis Be. Ltd. introduced the next-generation Stellar M22™ with XPL™ Technology during the 2025 Annual American Society for Dermatologic Surgery (ASDS) Meeting, highlighting single-session clearance rates of up to 100% for vascular and pigmented lesions. The multi-application aesthetic platform
- FDA Warns Websites Selling Unapproved Botulinum Toxin Productshttps://modernaesthetics.com/news/fda-warns-websites-selling-unapproved-botulinum-toxin-products/2484341/The US Food and Drug Administration (FDA) has issued 18 warning letters to website operators illegally marketing unapproved and misbranded botulinum toxin products for cosmetic and medical use. The enforcement action follows reports of adverse events, including sym
- InMode Appoints Michael Dennison as President of North Americahttps://modernaesthetics.com/news/inmode-appoints-michael-dennison-as-president-of-north-america/2484275/InMode Ltd has promoted Michael Dennison to president of North America, the company announced. Dennison previously served as vice president of sales. Dennison joined InMode nearly a decade ago and has held multiple leadership r
- Dermal Repair Complex Wins 2025 Nourish Award for Beauty and Collagen Supplementhttps://modernaesthetics.com/news/dermal-repair-complex-wins-2025-nourish-award-for-beauty-and-collagen-supplement/2484256/Beverly Hills MD Dermal Repair Complex has received the 2025 Nourish Award in the Beauty and Collagen category, according to a company announcement. The supplement, developed by cosmetic surgeons John Layke, DO, and Payman Danielpour, MD, is marketed as a skin-focused nutritional product formulat
- AAFPRS Highlights Energy-Based Device Trends Defining Aesthetic Advancements in 2025https://modernaesthetics.com/news/aafprs-highlights-energy-based-device-trends-defining-aesthetic-advancements-in-2025/2484060/The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) is spotlighting the latest innovations in energy-based devices (EBDs), signaling a shift toward increasingly personalized, nonsurgical facial rejuvenation in 2025.
- Dr. Woolery-Lloyd Appointed Program Development Advisor for Skin of Color Updatehttps://modernaesthetics.com/news/dr-woolery-lloyd-appointed-program-development-advisor-for-skin-of-color-update/2484015/Heather Woolery-Lloyd, MD, FAAD, has been appointed program development advisor for Skin of Color Update, the nation’s largest medical education event focused on dermatologic care for patients with skin of color. Dr. Woolery-Lloyd serves as director of the Skin of Color Division at the Uni
- PLADUOpro Plasma System Debuts in North Americahttps://modernaesthetics.com/news/pladuopro-plasma-system-debuts-in-north-america/2483995/Aesthetic Management Partners (AMP) announced the North American launch of PLADUOpro, a dual-gas plasma device designed to support noninvasive skin resurfacing and regeneration. The device, which integrates both argon and nitro
- Mayo Clinic Researchers Develop Fully Humanized 3D Bioprinted Skin Using Plant-Based Collagenhttps://modernaesthetics.com/news/mayo-clinic-researchers-develop-fully-humanized-3d-bioprinted-skin-using-plant-based-collagen/2483984/Mayo Clinic scientists have developed a fully humanized 3D bioprinted skin model using recombinant human collagen (rhCollagen) derived from plants, according to a study published in Archives of Dermatological Research.